Navigation Links
Pharmasset to Present at the JMP Healthcare Conference
Date:9/24/2010

PRINCETON, N.J., Sept. 24 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces that management will present at the JMP Healthcare Conference to be held September 27-28, 2010 at the New York Palace Hotel, New York, NY. Schaefer Price, Pharmasset's President and Chief Executive Officer, will provide an overview of the company at the JMP conference on Tuesday, September 28, 2010 at 10:00 AM (ET).

To access a simultaneous webcast of Mr. Price's overview via the internet, log on to the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm. Please connect to the website at least ten minutes prior to the start of the presentation to ensure adequate time for a reliable connection and any software download that may be necessary for the webcast.

A replay of the webcast will be available on Pharmasset's website for thirty days following the conference. The investor presentation will be available for download in PDF format immediately following the presentation in the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm.

About PharmassetPharmasset is a clinical-stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis C virus (HCV) and, secondarily, on the development of Racivir(TM) for the treatment of human immunodeficiency virus (HIV). Our research and development efforts focus on nucleoside/tide analogs, a class of compounds which act as alternative substrates for the viral polymerase, thus inhibiting viral replication. We cur
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmasset to Present at the UBS Global Life Sciences Conference
2. Pharmasset Initiates Phase 2b Clinical Trial of PSI-7977 for Chronic Hepatitis C Genotypes 1, 2, and 3
3. Pharmasset to Present at the 28th Annual JPMorgan Healthcare Conference
4. Pharmasset Reports Fiscal Year End 2009 Financial Results
5. Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C
6. Pharmasset to Present at Lazard Capital Markets Healthcare Conference
7. Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C
8. Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences
9. Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C
10. Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
11. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 Radiology information system ... used to store, manipulate, and distribute patient radiological ... tracking and scheduling system, result reporting, and an ... HIS and other databases improves the hospital workflow. ... scheduling, patient list management, radiology department workflow management, ...
(Date:12/19/2014)... Calif. , Dec. 18, 2014  Sage ... new generation of equipment for the testing of ... release of the new Luminary™ Profiler, the industry,s ... light-based measurement in a cost-effective, portable unit. ... the specific needs of the cannabis industry, the ...
(Date:12/19/2014)... 2014  RESMED INC. (NYSE: RMD ) today ... year 2015 results on Thursday, January 22, 2015, after the ... ResMed,s results will be issued after 1:00 p.m. US Pacific ... operating results and future outlook. The earnings call ... and the live webcast of the call can be accessed ...
Breaking Medicine Technology:The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2ResMed To Announce Second Quarter 2015 Results 2
... Androgen Deprivation and, Chemotherapy Reduced Size of Formerly Resistant Tumors ... Confirm Bavituximab,s Potential to Enhance Multiple ... Combination Regimens for Cancer Therapy -, ATLANTA, and TUSTIN, ... a clinical stage,biopharmaceutical company developing targeted monoclonal antibodies for the,treatment ...
... to More Effective Antibiotics Against ,Superbugs, BOSTON, ... of Engineering may have discovered the path,toward developing ... have developed resistance to common antibiotics. The,researchers have ... bacteria that opens to door to new avenues ...
Cached Medicine Technology:Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease 2Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease 3Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease 4Boston University Biomedical Engineers Find Chink in Bacteria's Armor 2Boston University Biomedical Engineers Find Chink in Bacteria's Armor 3
(Date:12/19/2014)... Wilmington, VT (PRWEB) December 19, 2014 ... full-service private ski club in Southern Vermont’s Deerfield Valley, ... trail names inspired by classic rock songs. , ... the weekend with a private concert followed by a ... said, “The new trail names include: “I’m Alright” the ...
(Date:12/19/2014)... HealthDay Reporter THURSDAY, Dec. ... might slightly reduce your risk of developing a form ... (Advil, Motrin) and naproxen (Aleve) appear to reduce the ... the researchers concluded after reviewing nine prior studies. Squamous ... These painkillers "have potential as part ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Dr. Myo Nwe ... Weight Loss Diet of the Future” and co-founder of the ... her book, Dr. Nwe takes a broad look at the ... hold up under scientific scrutiny. On film and in television ... emphasized mostly toward the social aspects and played for basic ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 In its ... and its Argus Claim Review division have recently ... the most common ways savings are achieved on behalf ... attributes millions of dollars in savings to Argus each ... 2013. , As explained by Tom Doney, Cypress president ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... one worrisome phenomenon is when an illness that originated in ... as zoonosis -- is not uncommon and keeps researchers on ... disease might make inroads into the human population. A ... the culprits in this case were guinea pigs. More specifically, ...
Breaking Medicine News(10 mins):Health News:The Hermitage Club Officially Names Four Ski Trails after Iconic Rock Songs by Grammy Award Winner Kenny Loggins 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 3Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2Health News:Out-of-Network & Medical Necessity Reviews among Top Ways TPA Identifies Significant Medical Claim Savings 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 3
... Focussing on healthcare needs of the country, Prime Minister ... National Development Council (NDC) to discuss disease control and ... to review the implementation of the National Rural Health ... attention to healthcare issues and ensure efficient functioning of ...
... to a new study at Cincinnati Children's Hospital Medical ... determine whether children with chronic diseases like Crohn's, juvenile ... cancer treatment -- are at increased risk for bone ... ,There is a huge demand for this ...
... in the Department of Obstetrics, Gynecology & Reproductive Sciences ... in understanding Fragile X mental retardation protein ... Fragile X syndrome(FXS). ,Fragile X syndrome, the ... by a mutation in the FMR1 gene on the ...
... of Florida researchers report the talcum powder stunts growth ... blood .The talc stimulates healthy cells to produce ... metastatic lung cancer. The UF researchers say talc is ... considered incurable. ,Talcum powder has been used ...
... Ministers of polio affected States organized today to review ... Health & Family Welfare, Dr. Anbumani Ramadoss said ... of immunity in all polio-affected States by vaccinating all ... immunization and Supplementary Immunization Activities (SIAs), so that the ...
... University Medical Center say they are moving closer to ... has become resistant to drug treatment in the ... construct, and then express in yeast, a protozoan gene ... they laboriously constructed over a two-year period is believed ...
Cached Medicine News:Health News:A Pratical Tool to Detect Bone Mass Deficiencies in Children With Chronic Diseases 2Health News:A Pratical Tool to Detect Bone Mass Deficiencies in Children With Chronic Diseases 3Health News:A Pratical Tool to Detect Bone Mass Deficiencies in Children With Chronic Diseases 4Health News:New Findings in Fragile X Mental Retardation Protein 2Health News:Talcum Powder Curbs Lung Tumor Risk 2Health News:Talcum Powder Curbs Lung Tumor Risk 3Health News:Every Child Needs to Be Vaccinated to Lead India into a Polio Free Future - Ramadoss 2Health News:New Insights into Antimalarial Drug Resistance 2Health News:New Insights into Antimalarial Drug Resistance 3Health News:New Insights into Antimalarial Drug Resistance 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: